Filters
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Inherited Bone Marrow Failure Panel PreventionGenetics, part of Exact Sciences United States | 266 | 186 |
|
GTC-Solid Tumor Profile Plus Fusion/Expression (DNA and RNA) Genomic Testing Cooperative, LCA United States | 1 | 434 |
|
Genomic Testing Cooperative, LCA United States | 1 | 434 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
qGenEx Intellectual disability Quantitative Genomic Medicine Laboratories, SL Spain | 3 | 1969 |
|
Hereditary Myeloid Malignancy Panel Genetic Services Laboratory University of Chicago United States | 37 | 85 |
|
NeoTYPE® Discovery Profile for Solid Tumors NeoGenomics Laboratories NeoGenomics Laboratories, Inc. United States | 1 | 315 |
|
Providence St. Joseph Health Molecular Genomics Laboratory Providence St Joseph Health United States | 1 | 523 |
|
Fanconi Anemia via the RAD51/FANCR Gene PreventionGenetics, part of Exact Sciences United States | 1 | 1 |
|
Genetic Services Laboratory University of Chicago United States | 20 | 19 |
|
PreventionGenetics, part of Exact Sciences United States | 20 | 22 |
|
Comprehensive Solid Tumor Panel Genomic Diagnostic Laboratory, Division of Genomic Diagnostics Children's Hospital of Philadelphia United States | 2 | 315 |
|
Fanconi anemia (NGS panel for 22 genes, including CNV analysis) CGC Genetics Unilabs Portugal | 1 | 22 |
|
Oncological diseases panel _v.2.0 CGC Genetics Unilabs Portugal | 1 | 205 |
|
Hematological Malignancies Hereditary Panel CGC Genetics Unilabs Portugal | 1 | 147 |
|
Haematological diseases panel _v.2.0 CGC Genetics Unilabs Portugal | 1 | 344 |
|
Bone Marrow Failure Syndrome Panel CGC Genetics Unilabs Portugal | 1 | 175 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.